Table 2.
L’Actuel PrEP Cohort follow-up status and median duration of PrEP use based on year of cohort entry (2013–2018)
| Follow-up status on July 31, 2018 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018* | Total | |||||||
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
| Active PrEP use† | 4 | 14.8 | 21 | 22.3 | 107 | 23.5 | 184 | 25.5 | 224 | 37.9 | 139 | 52.1 | 679 | 31.5 |
| Reported PrEP discontinuation | 8 | 29.6 | 15 | 16.0 | 68 | 14.9 | 93 | 12.9 | 66 | 11.2 | 16 | 6.0 | 266 | 12.3 |
| No PrEP follow-up ≥6 months | 11 | 40.7 | 44 | 46.8 | 212 | 46.6 | 221 | 30.6 | 116 | 19.6 | 2 | 0.7 | 606 | 28.1 |
| Did not initiate PrEP | 4 | 14.8 | 14 | 14.9 | 68 | 14.9 | 224 | 31.0 | 185 | 31.3 | 110 | 41.2 | 605 | 28.1 |
| Duration of PrEP use in months, median (IQR)‡ | 32.2 | (14.8–41.2) | 23.2 | (14.2–40.0) | 13.8 | (6.2–29.9) | 14.7 | (4.9–21.6) | 6.9 | (3.6–10.8) | 1.4 | (1.0–3.4) | 9.2 | (3.7–19.6) |
| Total PrEP consults | 27 | 1.3 | 94 | 4.4 | 455 | 21.1 | 722 | 33.5 | 591 | 27.4 | 267 | 12.4 | 2156 | 100 |
*Includes baseline consults from January 1 to June 30, 2018 only.
†Active PrEP use is defined as an open PrEP prescription at a PrEP follow-up visit within the past 6 months (February 1–July 31, 2018).
‡Duration of follow-up is measured among those who initiated PrEP.
PrEP, pre-exposure prophylaxis.